MedPath

Rice Intervention in Chronic Health Study

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Other: UKMRC9
Other: White rice
Registration Number
NCT06560541
Lead Sponsor
Taylor's University
Brief Summary

The goal of this clinical trial is to learn if the low glycemic index (GI), polyphenol-rich red pigmented rice (UKMRC9) works to improve cardio-metabolic parameters in Malaysian adults with type 2 diabetes (T2D) and healthy individuals. It will also learn about the molecular and metabolic effects of UKMRC9 as well as its consumer acceptance. The main questions it aims to answer are:

1. What are the effects of substituting white rice with UKMRC9 on cardio-metabolic parameters, including adiposity indices, glycemic control, lipid profiles, appetite hormones, total antioxidant capacity, inflammatory markers, blood pressure, and 10-year cardiovascular risk in Malaysian adults T2D patients and healthy individuals?

2. What are the effects of substituting white rice with UKMRC9 on urinary and plasma metabolome in Malaysian adults T2D patients and healthy individuals?

3. What are the effects of substituting white rice with UKMRC9 on mitochondrial DNA methylation and circulating exosomal microRNAs expression in Malaysian adults T2D patients and healthy individuals?

4. What is the difference in consumer acceptance toward UKMRC9 compared to white rice?

5. What are the facilitators and barriers to the inclusion of UKMRC9 as a staple food in Malaysian diet?

6. What are the dietary quality and dietary pattern among Malaysian adults T2D patients and healthy individuals?

7. What is the effects of substituting white rice with UKMRC9 on advanced glycation end (AGE) products among Malaysian adults T2D patients and healthy individuals?

Researchers will compare UKMRC9 to white rice to see if UKMRC9 works to improve cardio-metabolic parameters in Malaysian adults T2D patients and healthy individuals.

Participants will:

* Take UKMRC9 or white rice everyday for 24 weeks.

* Visit the study sites once every 12 weeks for follow-up assessments.

* Share their experience in substituting white rice with UKMRC9 in focus group discussion at the end of the intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
204
Inclusion Criteria
  • Attending outpatient clinics
  • Age 18 - 60 years (i.e. adult population)
  • Both male and female
  • Regular consumption of polished white rice (presumably high-GI) ≥ 200g/day
  • Established T2DM patients on oral medication
  • Glycated hemoglobin (HbA1c) 7% to 10%
  • Willing to take part and being compliant to the study protocol
Exclusion Criteria
  • Glycated hemoglobin (HbA1c) <7% or >10%
  • Use of insulin
  • A change in the type of treatment (e.g. insulin injection) during the intervention period
  • Regular consumption of low-GI rice types (basmati) or colored rice (red rice, purple rice, black rice) for ≥3 months.
  • Oral corticosteroids > 3 months
  • Pregnancy
  • Unstable medical condition.
  • Undergone any major operation in the past 3 months
  • Chronic alcohol drinker.
  • Not on weight loss diets or supplementation.
  • Taking part in another clinical trial.

Healthy arm:

Inclusion Criteria:

  • Healthy free living
  • With glycated haemoglobin (HbA1c <6.3%)
  • Age 18 - 60 years (i.e. adult population)
  • Both male and female
  • Regular consumption of polished white rice (presumably high-GI) ≥ 200g/day
  • Generally, physically and mentally healthy as per medical examination.
  • Willing to take part and being compliant to the study protocol.

Exclusion Criteria:

  • Regular consumption of low-GI rice types (basmati) or colored rice (red rice, purple rice, black rice) for ≥3 months
  • Presence of gastrointestinal disease, metabolic diseases such as diabetes, kidney failure, liver or pancreatic disease, hyperthyroidism, cancer or severe malnutrition.
  • Oral corticosteroids > 3 months
  • Pregnancy
  • Undergone any major operation in the past 3 months
  • Chronic alcohol drinker.
  • Not on weight loss diets or supplementation..
  • Taking part in another clinical trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Healthy Control Cohort Red Rice (HCC-RR)UKMRC9-
Diabetes Patients Cohort Red Rice (DPC-RR)UKMRC9-
Diabetes Patients Cohort White Rice (DPC-WR)White rice-
Healthy Control Cohort White Rice (HCC-WR)White rice-
Primary Outcome Measures
NameTimeMethod
Changes in urinary and plasma metabolomeBaseline versus 12-week versus 24-week

Effects of UKMRC9 on urinary and plasma metabolome

Changes in mitochondrial DNA methylation and circulating miRNAs expressionBaseline versus 24-week

Effects of UKMRC9 on mitochondrial DNA methylation and circulating miRNAs expression

Changes in cardio-metabolic parametersBaseline versus 12-week versus 24-week

Effects of UKMRC9 on cardio-metabolic parameters including adiposity indices, glycemic control, lipid profiles, appetite hormones, total antioxidant capacity, inflammatory markers, blood pressure, and 10-year cardiovascular risk

Secondary Outcome Measures
NameTimeMethod
Consumer Acceptance TestBaseline versus 12-week versus 24-week

Difference in consumer acceptance between UKMRC9 and white rice

Facilitators and Barriers to the Inclusion of UKMRC9 as a staple food24-week

Participants' experience of substituting white rice with UKMRC9 explored through the focus group discussions.

Dietary Pattern of Malaysian Adults with and without diabetesBaseline screening

The dietary pattern will be assessed at baseline using two distinct methods to provide a comprehensive evaluation of dietary intakes: (1) 3-day diet record, which will capture short-term food intakes and (2) food frequency questionnaire, which assess habitual, long term dietary intakes. The dietary data from each method will be reported in gram per day (g/d) and analysed separately using dimension reduction techniques to produce unified dietary pattern scores. This score will be categorized into tertiles (T1: 0-33.3%, T2: 33.4-66.7%, T3: 66.8-100%) for further analysis. Higher tertile indicates stronger adherence to the established dietary pattern.

Changes in Advanced Glycation End (AGEs) products measured by skin autofluorescence using AGE Reader mu (Diagnostics).Baseline versus 12-week versus 24-week

This outcome measure assesses the effects of UKMRC9 on the levels of advanced glycation end products (AGEs) as measured by skin autofluorescence, using the AGE Reader mu (Diagnostic). The results will be expressed in arbitrary units (AU)

Diet Quality of Malaysian Adults with and without diabetesBaseline screening

Diet quality will be benchmarked using the Healthy Eating Index (ranging from 0 to 100%), where a higher index indicates better diet quality.

Trial Locations

Locations (10)

Klinik Kesihatan Sungai Chua

🇲🇾

Kajang, Selangor, Malaysia

Institute for Medical Research

🇲🇾

Shah Alam, Selangor, Malaysia

The University of Nottingham Malaysia Compus

🇲🇾

Semenyih, Selangor, Malaysia

Klinik Kesihatan Bandar Baru Bangi

🇲🇾

Bangi, Selangor, Malaysia

Universiti Putra Malaysia

🇲🇾

Seri Kembangan, Selangor, Malaysia

Klinik Kesihatan Cheras

🇲🇾

Cheras, Kuala Lumpur, Malaysia

Hospital Canselor Tuanku Muhriz

🇲🇾

Cheras, Kuala Lumpur, Malaysia

Taylor's University

🇲🇾

Subang Jaya, Selangor, Malaysia

Hospital Pengajar Universiti Putra Malaysia

🇲🇾

Seri Kembangan, Selangor, Malaysia

Klinik Kesihatan Kajang

🇲🇾

Kajang, Selangor, Malaysia

© Copyright 2025. All Rights Reserved by MedPath